Homology Medicines, Inc. (FIXX) Social Stream



Homology Medicines, Inc. (FIXX): $1.17

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add FIXX to Watchlist
Sign Up

HOMOLOGY MEDICINES INC (FIXX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HOMOLOGY MEDICINES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 6 $30.001 $8 $23 $1.17 1865.81%
2022-01-31 6 $30 $8 $22 $1.17 1780.34%
2022-02-22 8 $30 $8 $23.4 $1.17 1900%
2022-03-25 8 $29 $8 $16.2 $1.17 1284.62%
2022-03-30 8 $29 $4 $15.4 $1.17 1216.24%
2022-05-16 8 $29 $4 $14 $1.17 1096.58%
2022-08-13 8 $29 $4 $13.833 $1.17 1082.31%
2022-08-22 8 $20 $4 $10.166 $1.17 768.89%
2022-09-17 9 $20 $4 $10 $1.17 754.7%
2022-11-11 9 $20 $3 $9 $1.17 669.23%
2022-11-17 8 $20 $3 $8.75 $1.17 647.86%
2023-02-08 9 $20 $3 $8.75 $1.17 647.86%
2023-03-12 8 $20 $2 $8.375 $1.17 615.81%
2023-03-16 9 $20 $2 $8.375 $1.17 615.81%
2023-05-15 9 $20 $2 $8.571 $1.17 632.56%
2023-06-06 9 $20 $2 $8.666 $1.17 640.68%
2023-07-28 2 $7 $1.5 $4.375 $1.17 273.93%

The Trend in the Analyst Price Target


FIXX's average price target has moved down $29 over the prior 39 months.

FIXX reports an average of 493.49% for its upside potential over the past 37 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-09 8 20 2.0 8.375 1.34 525%
2023-03-16 9 20 2.0 8.375 0.98 754.59%
2023-06-06 8 20 2.0 8.666 1.04 733.27%
2023-07-28 3 6 1.5 3.500 1.33 163.16%
2023-07-28 4 7 1.5 4.375 1.33 228.95%

FIXX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 18 months, FIXX's average broker recommendation rating worsened by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how HOMOLOGY MEDICINES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2486.14% of that group.
  • FIXX has a higher upside potential (average analyst target price relative to current price) than 2543.73% of all US stocks.
  • HOMOLOGY MEDICINES INC's number of analysts covering the stock is greater than 2129.31% of stocks in the small market cap category.
  • In terms of how HOMOLOGY MEDICINES INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 523.25% of that group.

Stocks similar to HOMOLOGY MEDICINES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BTAI, MBIO, and ACET.

Is FIXX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!